RLMD
Relmada Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +16.7% ·
aandelenstroom +30.0% ·
netto nieuwe posities +14.3%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 52 | +17 | 37.42M | $258.91M | +22 | −5 |
| Q1 2026 | 36 | +1 | 37.39M | $260.09M | +3 | −2 |
| Q4 2025 | 35 | +5 | 26.87M | $129.62M | +5 | n/a |
| Q3 2025 | 8 | 0 | 1.94M | $3.90M | n/a | n/a |
| Q2 2025 | 7 | +1 | 1.68M | $1.01M | +1 | n/a |
| Q1 2025 | 4 | 0 | 703.26K | $189,901 | n/a | n/a |
| Q4 2024 | 4 | -3 | 701.66K | $364,906 | n/a | −3 |
| Q3 2024 | 6 | 0 | 1.19M | $3.85M | n/a | n/a |
| Q2 2024 | 6 | n/a | 857.82K | $2.57M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Janus Henderson Group Plc | 7.27M | n/a | $35.04M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Adage Capital Partners ✦ | 4.27M | Nieuw | $20.62M | 0.0% | New | 1 | SEC ↗ |
| 3 | Marshall Wace ✦ | 3.19M | +1072.4% | $15.41M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 4 | Ameriprise Financial Inc | 1.92M | n/a | $9.27M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Millennium Management ✦ | 1.67M | Nieuw | $8.08M | 0.0% | New | 1 | SEC ↗ |
| 6 | Corient Private Wealth LP | 1.44M | n/a | $6.89M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | BlackRock ✦ (passief) | 1.27M | +149.5% | $6.12M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 8 | The Vanguard Group ✦ (passief) | 1.20M | +187.5% | $5.81M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 9 | Geode Capital Management ✦ (passief) | 854.93K | +188.6% | $4.13M | 0.0% | ▲ Add | 7 | SEC ↗ ×2 |
| 10 | Two Sigma Investments ✦ | 572.84K | +229.9% | $2.77M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 11 | Balyasny Asset Management L.P. | 547.85K | n/a | $2.65M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Susquehanna International Group, Llp | 385.94K | n/a | $1.86M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | State Street Global Advisors ✦ (passief) | 320.82K | +215.1% | $1.55M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Jane Street Group, Llc | 271.11K | n/a | $1.31M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 15 | Deutsche Bank Ag\ | 224.85K | n/a | $1.09M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 187.38K | Nieuw | $905,031 | 0.0% | New | 1 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 185.00K | +9.0% | $893,550 | 0.0% | ▲ Add | 7 | SEC ↗ |
| 18 | Northern Trust Corp | 165.45K | n/a | $799,138 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Qube Research & Technologies Ltd | 155.53K | n/a | $751,205 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Goldman Sachs Group ✦ | 145.00K | Nieuw | $700,350 | 0.0% | New | 1 | SEC ↗ |
| 21 | Squarepoint Ops LLC | 138.23K | n/a | $667,665 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Sei Investments Co | 98.97K | n/a | $478,001 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 62.36K | +5901.6% | $301,185 | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 24 | Barclays Plc | 60.00K | n/a | $289,800 | 0.0% | n/c | 1 | SEC ↗ |
| 25 | LMR Partners LLP | 55.60K | n/a | $268,548 | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Charles Schwab Investment… | 53.08K | n/a | $256,381 | 0.0% | n/c | 1 | SEC ↗ |
| 27 | UBS Group AG | 41.47K | n/a | $200,290 | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 28 | Citadel Advisors ✦ | 28.06K | Nieuw | $135,544 | 0.0% | New | 1 | SEC ↗ |
| 29 | Bank Of America Corp /De/ | 25.34K | n/a | $122,393 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 30 | Citigroup Inc | 22.53K | n/a | $108,839 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Simplex Trading, Llc | 18.61K | n/a | $89,891 | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Lido Advisors, LLC | 13.90K | n/a | $27,949 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Bnp Paribas Financial Markets | 3.04K | n/a | $14,683 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Royal Bank Of Canada | 2.04K | n/a | $10,000 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Osaic Holdings, Inc. | 5 | n/a | $24 | 0.0% | n/c | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Adage Capital Partners | $20.62M | 0.0% |
| Millennium Management | $8.08M | 0.0% |
| Point72 Asset Management | $905,031 | 0.0% |
| Goldman Sachs Group | $700,350 | 0.0% |
| Citadel Advisors | $135,544 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 103 houders, 83.66M aandelen, $576.39M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Officer, Director · Chief Executive… · 100.00K aand @ 4.10 · $410,000
Officer · Chief Financial… · 79.80K aand @ 4.25 · $339,150
Officer, Director · Chief Executive… · 100.00K aand @ 4.18 · $418,000
Officer · Chief Financial… · 120.20K aand @ 4.20 · $504,840
Open-market verkopen (S)
Geen open-market insider-verkopen in ons dekkingsvenster.
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie